Auf dieser Seite
PODD Insulet Corporation - Common Stock
NASDAQ · Health Care · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$131,69
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$126,4052-Wochen-Tief
$354,8852-Wochen-Hoch
Marktkapitalisierung (MRQ)
$9.13B
P/E (TTM)
24.7
EPS (TTM)
$5.33
Umsatz (TTM)
$3.05B
Ihre Abzeichen
52W-Spanne
$126–$355
Analystenbewertung
HOLD
Kursziel
$172
P/E
24.7
ROE
26.0%
Nettogewinnmarge
12.3%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
PODD Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$131.69
Marktkapitalisierung (MRQ)
$9.13B
P/E (TTM)
24.7
EPS (TTM)
$5.33
Umsatz (TTM)
$3.05B
ROE (TTM)
26.0%
Verschuldungsgrad (MRQ)
0.0
52W-Spanne
$126–$355
PODD Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$2.71B2017-12-31 → 2025-12-31
EPS$3.482017-12-31 → 2025-12-31
Freier Cashflow$378M2017-12-31 → 2025-12-31
Nettogewinnmarge12.3%2017-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | PODD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | 24.75-Jahres-Durchschnitt ≈1103.0 | ≈1103.0 | 28.6 | Fairer Wert | |
| P/S (TTM) | 3.05-Jahres-Durchschnitt ≈11.5 | ≈11.5 | 3.3 | Fairer Wert | |
| K/B (MRQ) | 6.45-Jahres-Durchschnitt ≈25.0 | ≈25.0 | 2.9 | Überbewertet | |
| Kurs / FCF (TTM) | 31.15-Jahres-Durchschnitt ≈-1004.0 | ≈-1004.0 | · | · | |
| Kurs / Cashflow (TTM) | 17.95-Jahres-Durchschnitt ≈16.7 | ≈16.7 | 16.9 | Überbewertet | |
| Kurs / Materieller Buchwert (MRQ) | 7.05-Jahres-Durchschnitt ≈31.0 | ≈31.0 | · | · | |
| PEG Ratio (PEG-Ratio) | ≈0.2 | · | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | PODD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Bruttogewinnmarge (TTM) | 71.1%5-Jahres-Durchschnitt ≈68.0% | ≈68.0% | 58.4% | Spitzenklasse | |
| Betriebsgewinnmarge (TTM) | 16.9%5-Jahres-Durchschnitt ≈11.9% | ≈11.9% | 11.9% | Spitzenklasse | |
| EBITDA-Marge (TTM) | 20.1%5-Jahres-Durchschnitt ≈16.3% | ≈16.3% | 13.1% | Spitzenklasse | |
| Vorgewinnmarge (TTM) | 16.2%5-Jahres-Durchschnitt ≈8.5% | ≈8.5% | 10.9% | Spitzenklasse | |
| Nettogewinnmarge (TTM) | 12.3%5-Jahres-Durchschnitt ≈8.7% | ≈8.7% | 8.1% | Spitzenklasse | |
| ROA (TTM) | 11.3%5-Jahres-Durchschnitt ≈6.4% | ≈6.4% | 3.2% | Spitzenklasse | |
| ROE (TTM) | 26.0%5-Jahres-Durchschnitt ≈17.5% | ≈17.5% | 5.8% | Spitzenklasse | |
| ROIC | 22.5%5-Jahres-Durchschnitt ≈17.9% | ≈17.9% | 5.5% | Spitzenklasse |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | PODD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital (MRQ) | 0.05-Jahres-Durchschnitt ≈1.1 | ≈1.1 | 0.6 | Geringe Verschuldung | |
| Liquiditätsgrad (MRQ) | 2.55-Jahres-Durchschnitt ≈3.9 | ≈3.9 | 2.5 | Im Einklang |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | PODD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | 30.7%5-Jahres-Durchschnitt ≈24.6% | ≈24.6% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 27.5%5-Jahres-Durchschnitt ≈24.8% | ≈24.8% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 24.5% | · | · | · | |
| EPS YoY (EPS VjV) | -39.8%5-Jahres-Durchschnitt ≈845.2% | ≈845.2% | · | · | |
| Net Income YoY (Nettogewinn YoY) | -40.9%5-Jahres-Durchschnitt ≈904.2% | ≈904.2% | · | · | |
| EPS CAGR 3Y (EPS CAGR 3J) | 267.7%5-Jahres-Durchschnitt ≈221.7% | ≈221.7% | · | · | |
| EPS CAGR 5Y (EPS CAGR 5J) | 103.4% | · | · | · | |
| Net Income CAGR 3Y (Nettoergebnis CAGR 3J) | 277.3%5-Jahres-Durchschnitt ≈227.1% | ≈227.1% | · | · | |
| Net Income CAGR 5Y (Nettoergebnis CAGR 5J) | 105.2% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | PODD | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.95-Jahres-Durchschnitt ≈0.7 | ≈0.7 | 0.5 | Spitzenklasse | |
| Inventory Turnover (Lagerumschlag) | 1.75-Jahres-Durchschnitt ≈1.5 | ≈1.5 | 2.1 | Schwach | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$501.5K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
14.6%
Nächster Bericht
Nov 04, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 5, 2026 | $1.66 | $1.48 | 12.2% |
| 31. März 2026 | $1.42 | $1.22 | 16.2% | |
| 31. Dezember 2025 | $1.55 | $1.48 | 4.5% | |
| 30. September 2025 | $1.24 | $1.16 | 6.5% | |
| 30. Juni 2025 | $1.17 | $0.95 | 23.7% | |
| 31. März 2025 | $1.01 | $0.81 | 24.5% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $2.71B | $2.07B | $1.70B | $1.31B | $1.10B | $904M | $738M | $564M | · | $367M | $264M | |
| Cost of Revenue | $768M | $626M | $537M | $500M | $347M | $322M | $258M | $194M | · | $156M | $131M | |
| Gross Profit | $1.94B | $1.45B | $1.16B | $806M | $752M | $582M | $480M | $370M | · | $211M | $133M | |
| R&D Expense | $301M | $220M | $205M | $180M | $160M | $147M | $132M | $95M | · | $56M | $43M | |
| SG&A Expense | $1.17B | $917M | $735M | $588M | $466M | $384M | $298M | $248M | · | $72M | $60M | |
| Operating Expenses | · | · | · | · | · | · | $430M | $343M | · | $222M | $182M | |
| Operating Income | $474M | $309M | $220M | $38M | $126M | $52M | $50M | $27M | · | $-11M | $-49M | |
| Interest Expense | · | · | $36M | $36M | $62M | $48M | $35M | $29M | · | $14M | $13M | |
| Interest Income | $35M | $40M | $29M | $9M | $500.0K | $3M | $7M | $8M | · | · | · | |
| Other Non-op | $14M | $-6M | $2M | $-1M | $-2M | $3M | $900.0K | $-900.0K | · | $825.0K | $58.0K | |
| Pretax Income | $340M | $300M | $215M | $10M | $20M | $10M | $14M | $5M | · | $-27M | $-61M | |
| Income Tax | $92M | $-118M | $8M | $5M | $4M | $3M | $3M | $2M | · | $392.0K | $212.0K | |
| Net Income | $247M | $418M | $206M | $5M | $17M | $7M | $12M | $3M | · | $-29M | $-74M | |
| EPS (Basic) | $3.51 | $5.97 | $2.96 | $0.07 | $0.25 | $0.11 | $0.19 | $0.06 | · | $-0.48 | · | |
| EPS (Diluted) | $3.48 | $5.78 | $2.94 | $0.07 | $0.24 | $0.10 | $0.19 | $0.05 | · | $-0.48 | · | |
| Shares (Basic) | 70,348,000 | 70,076,000 | 69,751,000 | 69,375,000 | 67,698,000 | 64,735,000 | 60,594,000 | 58,860,000 | · | 57,251,377 | · | |
| Shares (Diluted) | 71,886,000 | 73,891,000 | 73,633,000 | 69,910,000 | 68,579,000 | 65,946,000 | 62,304,000 | 61,008,000 | · | 57,251,377 | · | |
| EBITDA | $564M | $390M | $293M | $101M | $183M | $107M | $78M | · | · | $3M | $-45M |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | · | · | · | · | · | $907M | $214M | $114M | · | $137M | $123M | |
| Short-term Investments | · | · | · | · | · | · | · | $175M | · | $161M | $0 | |
| Receivables | $517M | · | · | $141M | $135M | $95M | $69M | $63M | · | $29M | $43M | |
| Inventory | $453M | $430M | $403M | $347M | $303M | $154M | $101M | $71M | $33M | $36M | $12M | |
| Prepaid Expense | $228M | $142M | $116M | $87M | $74M | $52M | $45M | $24M | $16M | $7M | $4M | |
| Other Current Assets | · | $92M | · | · | · | · | · | · | · | · | · | |
| Current Assets | $1.91B | $1.89B | $1.58B | $1.31B | $1.33B | $1.25B | $591M | $461M | $547M | $370M | $191M | |
| PP&E (Net) | · | · | · | $600M | $536M | $479M | $399M | $258M | · | $45M | $42M | |
| PP&E (Gross) | · | · | · | $835M | $716M | $607M | $490M | $324M | · | $84M | $70M | |
| Accum. Depreciation | · | · | · | $235M | $179M | $129M | $91M | $65M | · | $39M | $28M | |
| Goodwill | $52M | $52M | $52M | $52M | $40M | $40M | $40M | $40M | · | $40M | $40M | |
| Intangibles | $117M | $98M | $99M | $76M | $37M | $29M | $13M | $10M | · | $2M | $933.0K | |
| Other Non-current Assets | $288M | $182M | $188M | $210M | $106M | $77M | $41M | $2M | $15M | $216.0K | $76.0K | |
| Total Assets | $3.19B | $3.09B | $2.59B | $2.25B | $2.05B | $1.87B | $1.14B | $929M | $840M | $457M | $275M | |
| Accounts Payable | $75M | $20M | $19M | $31M | $38M | $54M | $54M | $26M | · | $13M | $15M | |
| Accrued Liabilities | $587M | · | · | $301M | $164M | $138M | $103M | $90M | · | $41M | $37M | |
| Current Liabilities | $680M | $528M | $451M | $365M | $229M | $208M | $158M | $116M | $89M | $56M | $65M | |
| Capital Leases | $49M | $40M | $30M | $27M | $8M | $12M | $14M | · | · | $0 | $269.0K | |
| Other Non-current Liabilities | $64M | $52M | $38M | $36M | $15M | $18M | $21M | $9M | $6M | $5M | $4M | |
| Total Liabilities | $1.68B | $1.88B | $1.86B | $1.77B | $1.49B | $1.27B | $1.07B | $717M | $661M | $393M | $241M | |
| Long-term Debt | · | · | · | $1.40B | $1.27B | $1.06B | $888M | $592M | · | $333M | $172M | |
| Total Debt | $18M | $84M | $49M | $1.40B | $1.27B | $1.06B | $888M | · | · | $333M | $172M | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $57.0K | $57.0K | |
| Paid-in Capital | $1.27B | $1.18B | $1.10B | $1.04B | $1.21B | $1.26B | $749M | $898M | · | $744M | $686M | |
| Retained Earnings | $287M | $40M | $-378M | $-584M | $-650M | $-666M | $-672M | $-684M | $-687M | $-680M | $-652M | |
| Treasury Stock | $60M | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $12M | $-13M | $8M | $20M | $-2M | $6M | $-1M | $-3M | · | $-726.0K | $-654.0K | |
| Stockholders' Equity | $1.52B | $1.21B | $733M | $476M | $556M | $604M | $76M | $212M | $179M | $63M | $34M | |
| Liabilities + Equity | $3.19B | $3.09B | $2.59B | $2.25B | $2.05B | $1.87B | $1.14B | $929M | $840M | $457M | $275M | |
| Shares Outstanding | 70,391,000 | 70,196,000 | 69,907,000 | 69,511,000 | 69,179,000 | 66,017,000 | 62,685,000 | 59,189,000 | · | 57,457,967 | 56,954,830 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $90M | $81M | $73M | $63M | $57M | $55M | $28M | $16M | · | $14M | $16M | |
| Stock-based Comp | $63M | $69M | $48M | $41M | $34M | $36M | $29M | $38M | · | $24M | $19M | |
| Deferred Tax | $62M | $-137M | $500.0K | $-900.0K | $1M | $-1M | $-700.0K | $-400.0K | · | $-199.0K | $-181.0K | |
| Amort. of Intangibles | $10M | $10M | $10M | $7M | $7M | $17M | $3M | $2M | · | $1M | $1M | |
| Restructuring | · | · | · | · | · | · | · | $1M | · | · | · | |
| Other Non-cash | $107M | $-1M | $-182M | $11M | $-178M | $-13M | $31M | · | · | $8M | $26M | |
| Operating Cash Flow | $569M | $430M | $146M | $119M | $-68M | $84M | $98M | $36M | · | $16M | $-13M | |
| CapEx | $192M | $125M | $76M | $123M | $112M | $129M | $164M | $157M | · | $22M | $11M | |
| Investing Cash Flow | $-223M | $-146M | $-119M | $-191M | $-83M | $14M | $-74M | $-184M | · | $-178M | $-15M | |
| Debt Issued | · | · | · | · | · | · | $780M | $0 | · | $334M | $0 | |
| Net Debt Issued | · | · | · | · | · | · | $780M | · | · | $334M | $0 | |
| Stock Issued | · | · | · | $0 | $0 | $478M | $0 | $0 | · | $5M | $8M | |
| Stock Repurchased | $60M | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | $-60M | · | · | $0 | $0 | $478M | · | · | · | $5M | $8M | |
| Financing Cash Flow | $-595M | $-28M | $-14M | $-40M | $41M | $606M | $74M | $-9M | · | $177M | $-371.0K | |
| Net Change in Cash | $-237M | $249M | $14M | $-117M | $-116M | $708M | $100M | $-159M | · | $15M | $-29M | |
| Taxes Paid | $38M | · | · | · | · | · | · | · | · | · | · | |
| Free Cash Flow | $378M | $305M | $70M | $-4M | $-180M | $-45M | $-65M | · | · | $-6M | $-23M | |
| Levered FCF | · | · | $35M | $-21M | $-231M | $-79M | $-93M | · | · | · | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 71.6% | 69.8% | 68.3% | 61.7% | 68.5% | 64.4% | 65.1% | · | · | 57.5% | 45.7% | |
| Operating Margin | 17.5% | 14.9% | 13.0% | 2.9% | 11.5% | 5.7% | 6.8% | · | · | -2.9% | -18.7% | |
| Net Margin | 9.1% | 20.2% | 12.2% | 0.35% | 1.5% | 0.75% | 1.6% | · | · | -7.9% | -22.7% | |
| Pretax Margin | 12.5% | 14.5% | 12.7% | 0.75% | 1.9% | 1.1% | 2.0% | · | · | -7.3% | -22.6% | |
| EBITDA Margin | 20.8% | 18.8% | 17.2% | 7.7% | 16.7% | 11.8% | 10.5% | · | · | 0.85% | -13.9% | |
| ROA | 7.9% | 14.7% | 8.5% | 0.21% | 0.86% | 0.45% | 1.1% | · | · | -7.9% | -25.7% | |
| ROE | 16.6% | 35.9% | 30.8% | 1.0% | 3.2% | 1.1% | 10.2% | · | · | -59.4% | -124.7% | |
| ROIC | 22.5% | 33.2% | 27.0% | 0.94% | 5.6% | 2.2% | 4.2% | · | · | -2.7% | -29.6% |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 3.6 | 3.5 | 3.6 | 5.8 | 6.0 | 3.7 | · | · | 6.6 | 2.9 | |
| Quick Ratio | · | · | · | 0.4 | 0.7 | 4.8 | 1.8 | · | · | 5.9 | 2.6 | |
| Debt / Equity | 0.0 | 0.1 | 0.1 | 2.9 | 2.3 | 1.8 | 11.7 | · | · | 5.3 | 5.0 | |
| LT Debt / Equity | · | · | · | 2.9 | 2.2 | 1.7 | 11.7 | · | · | 5.3 | 5.0 | |
| Interest Coverage | · | · | 6.1 | 1.0 | 2.0 | 1.1 | 1.4 | · | · | · | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.9 | 0.7 | 0.7 | 0.6 | 0.6 | 0.6 | 0.7 | · | · | 1.0 | 1.1 | |
| Inventory Turnover | 1.7 | 1.5 | 1.4 | 1.5 | 1.5 | 2.5 | 3.0 | · | · | 6.6 | 13.0 | |
| Receivables Turnover | · | · | · | 9.5 | 8.6 | 11.8 | 11.1 | · | · | 10.3 | 7.3 |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $21.53 | $17.26 | $10.48 | $6.85 | $8.04 | $9.14 | $1.21 | · | · | $1.10 | $0.60 | |
| Revenue / Share | $37.67 | $28.04 | $23.05 | $18.67 | $16.02 | $13.71 | $11.85 | · | · | · | · | |
| Cash Flow / Share | $7.92 | $5.82 | $1.98 | $1.70 | $-0.99 | $1.27 | $1.58 | · | · | · | · | |
| Cash / Share | · | · | · | · | · | $13.74 | $3.41 | · | · | $2.39 | $2.16 | |
| EPS (TTM) | $3.48 | $5.78 | $2.94 | $0.07 | $0.24 | $0.10 | $0.19 | $0.05 | · | $-0.48 | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 30.7% | 22.1% | 30.0% | 18.8% | 21.5% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | 27.5% | 23.5% | 23.3% | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 24.5% | · | · | · | · | · | · | · | · | · | · | |
| EPS YoY | -39.8% | 96.6% | 4100.0% | -70.8% | 140.0% | · | · | · | · | · | · | |
| EPS CAGR 3Y | 267.7% | 188.8% | 208.6% | · | · | · | · | · | · | · | · | |
| EPS CAGR 5Y | 103.4% | · | · | · | · | · | · | · | · | · | · | |
| Net Income YoY | -40.9% | 102.8% | 4384.8% | -72.6% | 147.1% | · | · | · | · | · | · | |
| Net Income CAGR 3Y | 277.3% | 192.0% | 211.9% | · | · | · | · | · | · | · | · | |
| Net Income CAGR 5Y | 105.2% | · | · | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $2.71B | $2.07B | $1.70B | $1.31B | $1.10B | $904M | $738M | $564M | · | $367M | $264M | |
| Net Income TTM | $247M | $418M | $206M | $5M | $17M | $7M | $12M | $3M | · | $-29M | $-74M | |
| Market Cap | $20.01B | $18.33B | $15.17B | $20.46B | $18.41B | $16.88B | $10.73B | · | · | $2.17B | $2.15B | |
| Enterprise Value | · | · | · | · | · | $17.03B | $11.41B | · | · | $2.20B | $2.20B | |
| P/E | 81.7 | 45.2 | 73.8 | 4205.6 | 1108.6 | 2556.3 | 901.1 | 1586.4 | · | -78.5 | · | |
| P/S | 7.4 | 8.8 | 8.9 | 15.7 | 16.8 | 18.7 | 14.5 | · | · | 5.9 | 8.2 | |
| P/B | 13.2 | 15.1 | 20.7 | 43.0 | 33.1 | 28.0 | 141.4 | · | · | 34.3 | 63.2 | |
| P / Tangible Book | 14.9 | 17.3 | 26.0 | 58.6 | 38.4 | 31.5 | · | · | · | · | · | |
| P / Cash Flow | 35.1 | 42.6 | 104.1 | 172.0 | -270.3 | 200.9 | 109.1 | · | · | 136.1 | -171.4 | |
| P / FCF | 53.0 | 60.0 | 216.4 | -5247.0 | -102.3 | -375.0 | -164.3 | · | · | -349.0 | -92.9 | |
| EV / EBITDA | · | · | · | · | · | 159.3 | 146.4 | · | · | 702.8 | -49.0 | |
| EV / FCF | · | · | · | · | · | -378.4 | -174.7 | · | · | -354.5 | -95.0 | |
| EV / Revenue | · | · | · | · | · | 18.8 | 15.5 | · | · | 6.0 | 8.3 | |
| Earnings Yield | 1.2% | 2.2% | 1.4% | 0.02% | 0.09% | 0.04% | 0.11% | 0.06% | · | -1.3% | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $802M | $762M | $784M | $706M | $649M | $569M | $598M | $544M | $488M | $442M | $510M | $433M | $396M | $358M | $370M | $341M | |
| Cost of Revenue | $239M | $233M | $215M | $196M | $197M | $160M | $167M | $167M | $158M | $135M | $149M | $139M | $132M | $118M | $152M | $152M | |
| Gross Profit | $563M | $529M | $569M | $510M | $452M | $409M | $431M | $377M | $331M | $307M | $361M | $293M | $265M | $240M | $217M | $188M | |
| R&D Expense | $88M | $90M | $91M | $77M | $73M | $60M | $61M | $55M | $54M | $50M | $42M | $58M | $55M | $50M | $50M | $45M | |
| SG&A Expense | $345M | $317M | $332M | $315M | $258M | $261M | $261M | $234M | $222M | $200M | $213M | $181M | $179M | $163M | $144M | $140M | |
| Operating Income | $130M | $122M | $146M | $118M | $121M | $89M | $109M | $88M | $54M | $57M | $106M | $55M | $31M | $28M | $24M | $3M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $11M | · | $10M | $10M | $9M | · | $9M | |
| Interest Income | $4M | $5M | $6M | $9M | $10M | $10M | $10M | $10M | $9M | $9M | $6M | $9M | $7M | $6M | $6M | $2M | |
| Other Non-op | $-1M | $700.0K | $3M | $12M | $1M | $-2M | $400.0K | $-3M | $-2M | $-700.0K | $2M | $700.0K | $-200.0K | $-200.0K | $2M | $-2M | |
| Pretax Income | $119M | $113M | $140M | $123M | $28M | $48M | $111M | $83M | $51M | $55M | $108M | $54M | $28M | $25M | $22M | $-6M | |
| Income Tax | $24M | $22M | $39M | $35M | $6M | $13M | $11M | $5M | $-138M | $3M | $4M | $2M | $1M | $800.0K | $5M | $-500.0K | |
| Net Income | $95M | $91M | $102M | $88M | $22M | $35M | $101M | $78M | $189M | $52M | $103M | $52M | $27M | $24M | $17M | $-5M | |
| EPS (Basic) | $1.37 | $1.30 | $1.45 | $1.24 | $0.32 | $0.50 | $1.43 | $1.11 | $2.69 | $0.74 | $1.49 | $0.74 | $0.39 | $0.34 | $0.25 | $-0.08 | |
| EPS (Diluted) | $1.37 | $1.30 | $1.42 | $1.24 | $0.32 | $0.50 | $1.38 | $1.08 | $2.59 | $0.73 | $1.47 | $0.74 | $0.39 | $0.34 | $0.25 | $-0.08 | |
| Shares (Basic) | 69,298,000 | 69,986,000 | · | 70,367,000 | 70,389,000 | 70,272,000 | · | 70,123,000 | 70,062,000 | 69,957,000 | · | 69,823,000 | 69,741,000 | 69,583,000 | · | 69,418,000 | |
| Shares (Diluted) | 69,403,000 | 70,202,000 | · | 70,661,000 | 70,652,000 | 74,111,000 | · | 73,951,000 | 73,802,000 | 73,741,000 | · | 73,624,000 | 70,142,000 | 70,096,000 | · | 69,418,000 | |
| EBITDA | $130M | $148M | · | $118M | $121M | $110M | · | $88M | $55M | $76M | · | $55M | $31M | $45M | · | $3M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Receivables | $589M | $545M | · | · | · | · | · | · | · | · | · | · | · | $160M | · | $153M | |
| Inventory | $485M | $462M | $453M | $446M | $447M | $441M | $430M | $445M | $431M | $431M | · | $411M | $411M | $386M | · | $328M | |
| Prepaid Expense | $241M | $222M | $228M | $73M | $267M | $202M | $142M | $138M | $148M | $116M | · | $105M | $100M | $106M | · | $78M | |
| Other Current Assets | · | · | · | $121M | · | · | · | · | · | · | · | · | · | · | · | · | |
| Current Assets | $1.85B | $1.71B | $1.91B | $1.86B | $2.28B | $2.33B | $1.89B | $1.86B | $1.75B | $1.62B | · | $1.47B | $1.42B | $1.33B | · | $1.33B | |
| PP&E (Net) | · | · | · | · | · | · | · | · | · | · | · | · | $602M | $597M | · | $553M | |
| Goodwill | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | $52M | |
| Intangibles | $115M | $115M | $117M | $105M | $102M | $100M | $98M | $100M | $98M | $98M | · | $100M | $100M | $100M | · | $54M | |
| Other Non-current Assets | $291M | $281M | $206M | $188M | $315M | $319M | $182M | $166M | $164M | $188M | · | $196M | $212M | $211M | · | $179M | |
| Total Assets | $3.17B | $2.99B | $3.19B | $3.03B | $3.47B | $3.52B | $3.09B | $3.03B | $2.88B | $2.62B | · | $2.47B | $2.39B | $2.29B | · | $2.17B | |
| Accounts Payable | $123M | $150M | $75M | $48M | $96M | $58M | $20M | $40M | $77M | $76M | · | $78M | $108M | $86M | · | $62M | |
| Accrued Liabilities | $602M | $519M | · | · | · | · | · | · | · | · | · | · | · | $264M | · | $242M | |
| Current Liabilities | $744M | $688M | $680M | $648M | $1.01B | $520M | $528M | $506M | $486M | $432M | · | $451M | $425M | $383M | · | $334M | |
| Capital Leases | · | · | $49M | · | · | · | $40M | · | · | · | · | $30M | · | · | · | · | |
| Other Non-current Liabilities | $69M | $68M | $64M | $63M | $57M | $54M | $52M | $45M | $37M | $38M | · | $38M | $38M | $34M | · | $24M | |
| Total Liabilities | $1.74B | $1.68B | $1.68B | $1.65B | $2.01B | $2.19B | $1.88B | $1.91B | $1.88B | $1.83B | · | $1.86B | $1.83B | $1.79B | · | $1.74B | |
| Long-term Debt | · | · | · | · | · | · | · | · | · | · | · | · | $1.40B | $1.40B | · | $1.41B | |
| Total Debt | $19M | $19M | · | $80M | $461M | $83M | · | $42M | $38M | $39M | · | $50M | $1.40B | $1.40B | · | $1.41B | |
| Common Stock | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | $100.0K | · | $100.0K | $100.0K | $100.0K | · | $100.0K | |
| Paid-in Capital | $1.31B | $1.28B | $1.27B | $1.25B | $1.38B | $1.26B | $1.18B | $1.16B | $1.14B | $1.12B | · | $1.08B | $1.07B | $1.05B | · | $1.02B | |
| Retained Earnings | $474M | $378M | $287M | $186M | $98M | $76M | $40M | $-60M | $-138M | $-326M | · | $-481M | $-533M | $-560M | · | $-601M | |
| Treasury Stock | $364M | $363M | $60M | $60M | $31M | · | $0 | · | · | · | · | · | · | · | · | · | |
| AOCI | $2M | $6M | $12M | $12M | $15M | $-6M | $-13M | $20M | $-4M | $-500.0K | · | $8M | $16M | $16M | · | $7M | |
| Stockholders' Equity | $1.42B | $1.30B | $1.52B | $1.38B | $1.46B | $1.33B | $1.21B | $1.12B | $998M | $791M | $733M | $608M | $554M | $503M | $476M | $428M | |
| Liabilities + Equity | $3.17B | $2.99B | $3.19B | $3.03B | $3.47B | $3.52B | $3.09B | $3.03B | $2.88B | $2.62B | · | $2.47B | $2.39B | $2.29B | · | $2.17B | |
| Shares Outstanding | 69,351,000 | 69,264,000 | 70,390,816 | 70,346,000 | 70,391,000 | 70,361,846 | 70,196,031 | 70,141,692 | 70,112,039 | 70,020,202 | 69,907,000 | 69,825,875 | 69,804,489 | 69,694,363 | 69,511,000 | 69,431,159 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $27M | $26M | $24M | $22M | $22M | $22M | $22M | $21M | $19M | $19M | $19M | $19M | $18M | $17M | $16M | $16M | |
| Stock-based Comp | $20M | $21M | $20M | $17M | $8M | $18M | $20M | $18M | $17M | $14M | $13M | $10M | $13M | $12M | $11M | $9M | |
| Amort. of Intangibles | · | · | $3M | $3M | $3M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $2M | $2M | $2M | |
| Other Non-cash | · | $-25M | · | · | · | $-12M | · | · | · | $3M | · | · | · | $-53M | · | · | |
| Operating Cash Flow | $88M | $114M | $183M | $126M | $196M | $64M | $148M | $99M | $87M | $88M | $45M | $56M | $44M | $500.0K | $51M | $57M | |
| CapEx | $32M | $24M | $135M | $26M | $19M | $12M | $54M | $27M | $22M | $22M | $29M | $20M | $16M | $10M | $64M | $31M | |
| Investing Cash Flow | $-37M | $-28M | $-153M | $-31M | $-23M | $-16M | $-68M | $-29M | $-25M | $-24M | $-32M | $-23M | $-23M | $-42M | $-88M | $-34M | |
| Stock Repurchased | $0 | $300M | $0 | $30M | $30M | $0 | $0 | $0 | · | · | · | · | · | · | · | · | |
| Net Stock Activity | · | $-300M | · | · | · | · | · | · | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $4M | $-320M | $-72M | $-457M | $-344M | $278M | $-21M | $8M | $9M | $-14M | $2M | $-7M | $3M | $-12M | $-14M | $-4M | |
| Net Change in Cash | $54M | $-236M | $-41M | $-364M | $-162M | $330M | $51M | $82M | $70M | $47M | $19M | $25M | $24M | $-54M | $-47M | $13M | |
| Free Cash Flow | · | $90M | · | · | · | $52M | · | · | · | $66M | · | · | · | $-10M | · | · | |
| Levered FCF | · | · | · | · | · | · | · | · | · | $55M | · | · | · | $-19M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 70.2% | 69.5% | · | 72.2% | 69.7% | 71.9% | · | 69.3% | 67.7% | 69.5% | · | 67.8% | 66.8% | 67.2% | · | 55.2% | |
| Operating Margin | 16.2% | 16.0% | · | 16.7% | 18.7% | 15.6% | · | 16.2% | 11.2% | 12.9% | · | 12.7% | 7.8% | 7.7% | · | 0.85% | |
| Net Margin | 11.8% | 12.0% | · | 12.4% | 3.5% | 6.2% | · | 14.2% | 38.6% | 11.7% | · | 12.0% | 6.9% | 6.7% | · | -1.5% | |
| Pretax Margin | 14.8% | 14.8% | · | 17.4% | 4.4% | 8.5% | · | 15.2% | 10.5% | 12.4% | · | 12.4% | 7.2% | 6.9% | · | -1.7% | |
| EBITDA Margin | 16.2% | 19.5% | · | 16.7% | 18.7% | 19.4% | · | 16.2% | 11.2% | 17.1% | · | 12.7% | 7.8% | 12.5% | · | 0.85% | |
| ROA | 2.9% | 2.8% | · | 2.9% | 0.71% | 1.1% | · | 2.8% | 7.2% | 2.1% | · | 2.2% | 1.2% | 1.1% | · | -0.25% | |
| ROE | 6.6% | 6.9% | · | 7.0% | 1.8% | 3.3% | · | 9.0% | 24.3% | 8.0% | · | 10.0% | 5.6% | 5.0% | · | -1.1% | |
| ROIC | 7.2% | 7.4% | · | 5.7% | 5.0% | 4.6% | · | 7.1% | 19.4% | 6.4% | · | 8.1% | 1.5% | 1.4% | · | 0.14% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.5 | 2.5 | · | 2.9 | 2.3 | 4.5 | · | 3.7 | 3.6 | 3.7 | · | 3.3 | 3.3 | 3.5 | · | 4.0 | |
| Quick Ratio | 0.8 | 0.8 | · | · | · | · | · | · | · | · | · | · | · | 0.4 | · | 0.5 | |
| Debt / Equity | 0.0 | 0.0 | · | 0.1 | 0.3 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.1 | 2.5 | 2.8 | · | 3.3 | |
| LT Debt / Equity | · | · | · | · | · | · | · | · | · | · | · | · | 2.5 | 2.7 | · | 3.2 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | 5.3 | · | 5.3 | 3.2 | 2.9 | · | 0.3 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | 0.2 | 0.2 | · | 0.2 | |
| Inventory Turnover | 0.5 | 0.5 | · | 0.4 | 0.4 | 0.4 | · | 0.4 | 0.4 | 0.3 | · | 0.4 | 0.4 | 0.3 | · | 0.5 | |
| Receivables Turnover | 2.2 | 2.2 | · | · | · | · | · | · | · | · | · | · | · | 2.3 | · | 2.5 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $20.51 | $18.81 | · | $19.68 | $20.78 | $18.91 | · | $15.94 | $14.24 | $11.29 | · | $8.70 | $7.93 | $7.21 | · | $6.16 | |
| Revenue / Share | $11.55 | $10.85 | · | $10.00 | $9.19 | $7.68 | · | $7.35 | $6.62 | $5.99 | · | $5.88 | $5.65 | $5.11 | · | $4.91 | |
| Cash Flow / Share | · | $1.62 | · | · | · | $0.86 | · | · | · | $1.19 | · | · | · | $0.01 | · | · | |
| EPS (TTM) | $5.33 | $4.28 | · | $3.44 | $3.28 | $5.55 | · | $5.87 | $5.53 | $3.33 | · | $1.72 | $0.90 | $0.01 | · | $0.25 |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $3.05B | $2.90B | · | $2.52B | $2.36B | $2.20B | · | $1.98B | $1.87B | $1.78B | · | $1.56B | $1.47B | $1.37B | · | $1.24B | |
| Net Income TTM | $375M | $303M | · | $246M | $236M | $402M | · | $421M | $395M | $234M | · | $120M | $63M | $600.0K | · | $17M | |
| Market Cap | $10.56B | $14.53B | · | $21.72B | $22.12B | $18.48B | · | $16.33B | $14.15B | $12.00B | · | $11.14B | $20.13B | $22.23B | · | $15.93B | |
| P/E | 28.6 | 49.0 | · | 89.7 | 95.8 | 47.3 | · | 39.7 | 36.5 | 51.5 | · | 92.7 | 320.4 | 31896.0 | · | 917.6 | |
| P/S | 3.5 | 5.0 | · | 8.6 | 9.4 | 8.4 | · | 8.2 | 7.6 | 6.7 | · | 7.2 | 13.7 | 16.2 | · | 12.8 | |
| P/B | 7.4 | 11.2 | · | 15.7 | 15.1 | 13.9 | · | 14.6 | 14.2 | 15.2 | · | 18.3 | 36.3 | 44.2 | · | 37.2 | |
| P / Tangible Book | 8.4 | 12.8 | · | 17.7 | 16.9 | 15.7 | · | 16.9 | 16.7 | 18.7 | · | 24.4 | 50.0 | 63.4 | · | 49.4 | |
| P / Cash Flow | · | 127.7 | · | · | · | 289.6 | · | · | · | 137.0 | · | · | · | 44459.4 | · | · | |
| Earnings Yield | 3.5% | 2.0% | · | 1.1% | 1.0% | 2.1% | · | 2.5% | 2.7% | 1.9% | · | 1.1% | 0.31% | 0.00% | · | 0.11% |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $2.71B | $2.07B | $1.70B | $1.31B | $1.10B |
| Bruttogewinnmarge % | 71.6% | 69.8% | 68.3% | 61.7% | 68.5% |
| Betriebsgewinnmarge % | 17.5% | 14.9% | 13.0% | 2.9% | 11.5% |
| Nettoergebnis | $247M | $418M | $206M | $5M | $17M |
| Verwässerte EPS | $3.48 | $5.78 | $2.94 | $0.07 | $0.24 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Fremdkapital / Eigenkapital | 0.0 | 0.1 | 0.1 | 2.9 | 2.3 |
| Liquiditätsgrad | 2.8 | 3.6 | 3.5 | 3.6 | 5.8 |
| Quick Ratio | · | · | · | 0.4 | 0.7 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $378M | $305M | $70M | $-4M | $-180M |
Institutionelle Eigentümer (13F) 785 Einreicher · $13.1B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
785
Gehaltener Wert
$13.1B
Neue Positionen
95
Geschlossene Positionen
133
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 95 (-5 vs. Vorquartal) | 133 (+15 vs. Vorquartal) | 326 (+8 vs. Vorquartal) | 244 (-21 vs. Vorquartal) | +2.5M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| VANGUARD GROUP INC | $2.473.306.401 | 8.701.472 | 18,89% | Aktien |
| BlackRock, Inc. | $1.018.581.758 | 6.690.192 | 7,78% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $688.981.949 | 4.525.333 | 5,26% | Aktien |
| STATE STREET CORP | $486.827.749 | 3.197.555 | 3,72% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $468.310.647 | 3.075.932 | 3,58% | Aktien |
| AQR CAPITAL MANAGEMENT LLC | $373.794.275 | 2.455.135 | 2,86% | Aktien |
| BAILLIE GIFFORD & CO | $310.942.153 | 2.042.313 | 2,38% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $303.968.212 | 2.003.861 | 2,32% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $289.843.502 | 1.903.734 | 2,21% | Aktien |
| Invesco Ltd. | $258.010.608 | 1.694.651 | 1,97% | Aktien |
| MORGAN STANLEY | $225.185.911 | 1.479.050 | 1,72% | Aktien |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | $223.970.255 | 1.471.069 | 1,71% | Aktien |
| Clearbridge Investments, LLC | $200.875.774 | 1.319.381 | 1,53% | Aktien |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $166.895.612 | 795.347 | 1,27% | Aktien |
| Soleus Capital Management, L.P. | $159.710.250 | 1.049.000 | 1,22% | Aktien |
| NORGES BANK | $159.555.869 | 1.047.986 | 1,22% | Aktien |
| JUPITER ASSET MANAGEMENT LTD | $156.313.705 | 1.026.691 | 1,19% | Aktien |
| FMR LLC | $146.814.214 | 964.297 | 1,12% | Aktien |
| MILLENNIUM MANAGEMENT LLC | $131.755.171 | 865.387 | 1,01% | Aktien |
| FIL Ltd | $127.893.958 | 840.026 | 0,98% | Aktien |
| GOLDMAN SACHS GROUP INC | $124.580.823 | 818.265 | 0,95% | Aktien |
| CITADEL ADVISORS LLC | $121.304.578 | 796.746 | 0,93% | Aktien |
| FEDERATED HERMES, INC. | $106.909.036 | 702.194 | 0,82% | Aktien |
| Vestal Point Capital, LP | $102.007.500 | 670.000 | 0,78% | Aktien |
| Qube Research & Technologies Ltd | $101.089.128 | 663.968 | 0,77% | Aktien |
| NORTHERN TRUST CORP | $98.948.496 | 649.908 | 0,76% | Aktien |
| NORDEA INVESTMENT MANAGEMENT AB | $95.186.432 | 618.174 | 0,73% | Aktien |
| FRONTIER CAPITAL MANAGEMENT CO LLC | $94.776.509 | 622.506 | 0,72% | Aktien |
| JPMORGAN CHASE & CO | $94.387.914 | 595.123 | 0,72% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $91.025.860 | 597.871 | 0,70% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $83.386.262 | 547.577 | 0,64% | Aktien |
| UBS Group AG | $82.676.317 | 543.030 | 0,63% | Aktien |
| Man Group plc | $78.746.289 | 517.217 | 0,60% | Aktien |
| Amundi | $77.319.766 | 507.847 | 0,59% | Aktien |
| AMERIPRISE FINANCIAL INC | $77.111.303 | 506.374 | 0,59% | Aktien |
| Alecta Tjanstepension Omsesidigt | $71.461.456 | 469.400 | 0,55% | Aktien |
| Vinva Investment Management Ltd | $68.542.735 | 430.460 | 0,52% | Aktien |
| D. E. Shaw & Co., Inc. | $64.937.670 | 426.520 | 0,50% | Aktien |
| BANK OF AMERICA CORP /DE/ | $64.920.770 | 426.409 | 0,50% | Aktien |
| Bank of New York Mellon Corp | $60.615.312 | 398.130 | 0,46% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $60.598.088 | 398.017 | 0,46% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $55.989.000 | 367.746 | 0,43% | Aktien |
| WESTFIELD CAPITAL MANAGEMENT CO LP | $53.701.163 | 352.717 | 0,41% | Aktien |
| Stephens Investment Management Group LLC | $51.421.981 | 337.747 | 0,39% | Aktien |
| DEUTSCHE BANK AG\ | $51.152.957 | 335.980 | 0,39% | Aktien |
| Quantinno Capital Management LP | $48.251.490 | 316.922 | 0,37% | Aktien |
| Legal & General Group Plc | $47.418.567 | 311.452 | 0,36% | Aktien |
| Nuveen, LLC | $44.125.248 | 289.821 | 0,34% | Aktien |
| Aberdeen Group plc | $43.823.641 | 287.840 | 0,33% | Aktien |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | $41.668.085 | 273.682 | 0,32% | Aktien |
Aktivisten & 5%+-Eigentümer 1 Beteiligung
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC, OrbiMed Capital GP II LLC, Samuel D. Isaly ×3 Einreichungen | 10. April 2008 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 78 Insider · 44 Führungskräfte · 27 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Ashley Mcevoy | President and CEO | 21. August 2026 P | 23.731 | 2 | 0 | $1.191.422 |
| James Hollingshead | Former President and CEO | 28. April 2025 F | 61.247 | 0 | 0 | $0 |
| SULLIVAN PATRICK J | CEO and Chairman of the Board | 29. März 2018 F | 322.752 | 0 | 0 | $0 |
| Duane Desisto | President and CEO | 2. September 2014 M | 257.184 | 0 | 0 | $0 |
| Flavia Pease | EVP & CFO | 24. Februar 2026 A | 19.159 | 0 | 0 | $0 |
| Ana Maria Chadwick | EVP, CFO & Treasurer | 1. Mai 2025 F | 14.263 | 0 | 0 | $0 |
| Wayde D. Mcmillan | EVP, CFO | 3. Juli 2023 S | 21.477 | 0 | 0 | $0 |
| Michael L Levitz | SVP and CFO | 27. Februar 2019 S | 56.651 | 0 | 0 | $0 |
| Allison Dorval | Chief Financial Officer | 1. April 2015 F | 37.415 | 0 | 0 | $0 |
| Brian K Roberts | Chief Financial Officer | 1. April 2014 F | 120.050 | 0 | 0 | $0 |
| Eric Benjamin | EVP and COO | 27. Februar 2026 F | 23.600 | 0 | 0 | $0 |
| William Patrick Ryan | Chief Operating Officer | 5. Mai 2015 P | 47.990 | 0 | 0 | $0 |
| Luis Malave | Chief Operating Officer | 1. März 2010 A | 195.857 | 0 | 0 | $0 |
| Lisa Blair Davis | SVP, Chief HR Officer | 1. August 2026 F | 4.453 | 0 | 0 | $0 |
| Michael Panos | EVP and CCO | 1. April 2026 A | 2.782 | 0 | 0 | $0 |
| Prem Singh | SVP, Global Operations | 27. Februar 2026 F | 6.891 | 0 | 0 | $0 |
| Laetitia Cousin | SVP, Reg, Quality & Compliance | 27. Februar 2026 F | 5.674 | 0 | 0 | $0 |
| Lauren Budden | Group VP, CAO and Controller | 27. Februar 2026 F | 8.526 | 0 | 0 | $0 |
| John W. Kapples | SVP and General Counsel | 27. Februar 2026 F | 27.514 | 0 | 0 | $0 |
| Dan Manea | SVP, Chief HR Officer | 13. Juni 2025 S | 9.090 | 0 | 0 | $0 |
| Mark N Field | SVP & Chief Technology Officer | 28. Februar 2025 F | 13.411 | 0 | 0 | $0 |
| Charles Alpuche | Advisor | 14. März 2023 M | 56.954 | 0 | 0 | $0 |
| Spears Michael P | Advisor | 9. März 2023 M | 13.645 | 0 | 0 | $0 |
| Bret Christensen | EVP and CCO | 28. Februar 2023 A | 20.178 | 0 | 0 | $0 |
| David Colleran | SVP, Secretary and GC | 2. April 2019 M | 30.433 | 0 | 0 | $0 |
| Aiman Abdel-Malek | EVP & Chief Technology Officer | 28. März 2019 F | 19.687 | 0 | 0 | $0 |
| Bradley A Thomas | EVP Human Resources | 29. März 2018 F | 65.818 | 0 | 0 | $0 |
| Daniel J Levangie | EVP & President, Drug Delivery | 30. April 2016 F | 21.122 | 0 | 0 | $0 |
| Anthony R Diehl | Secretary and General Counsel | 11. Mai 2015 M | 40.854 | 0 | 0 | $0 |
| Peter Devlin | Chief Commercial Officer | 9. Juni 2014 S | 67.354 | 0 | 0 | $0 |
| Tracey Haas Wielinski | VP, Global Regulatory, CA, QA | 6. März 2014 M | 24.000 | 0 | 0 | $0 |
| Ruthann Depietro | Vice President of Quality | 4. September 2012 M | 18.351 | 0 | 0 | $0 |
| Carsten Boess | Vice President, International | 25. April 2011 M | 18.941 | 0 | 0 | $0 |
| Robert Campbell | Vice President for Clinical | 25. Januar 2010 M | 63.633 | 0 | 0 | $0 |
| David A Howe | VP of Human Resources | 26. Februar 2009 A | · | 0 | 0 | $0 |
| Jason Ng | Vice President of Asian Operat | 26. Februar 2009 A | · | 0 | 0 | $0 |
| Lars Boesgaard | Vice President of Finance | 26. Februar 2009 A | · | 0 | 0 | $0 |
| Shawna Gvazdauskas | Senior Vice President of Sales | 26. Februar 2009 A | 0 | 0 | 0 | $0 |
| John Garibotto | Vice President of Research | 26. Februar 2009 A | · | 0 | 0 | $0 |
| Kevin Schmid | VP of Operations & Engineering | 26. Februar 2009 A | 17.500 | 0 | 0 | $0 |
| William D Arthur III | V.P. of Business Development | 26. Februar 2009 A | · | 0 | 0 | $0 |
| Andrew Suchoff | Chief Human Resources Officer | 27. März 2008 A | · | 0 | 0 | $0 |
| Jefferey Smith | Vice President of Marketing | 12. März 2008 A | · | 0 | 0 | $0 |
| Stephen Bubrick | Vice President of Customer | 9. August 2007 A | · | 0 | 0 | $0 |
| Robert Luther Huffines | Direktor | 30. September 2026 A | 2.627 | 0 | 0 | $0 |
| Jonathan Jay Mazelsky | Direktor | 30. September 2026 A | 1.496 | 0 | 0 | $0 |
| Luciana Borio | Direktor | 3. Juni 2026 S | 4.329 | 0 | 1 | $-59.887 |
| Timothy C. Stonesifer | Direktor | 3. Juni 2026 P | 9.041 | 2 | 0 | $700.277 |
| Elizabeth H Weatherman | Direktor | 3. Juni 2026 P | 10.352 | 1 | 0 | $497.490 |
| Wayne A.I. Frederick | Direktor | 20. Mai 2026 A | 3.818 | 0 | 1 | $-542.510 |
| Jessica Hopfield | Direktor | 20. Mai 2026 A | 29.355 | 0 | 0 | $0 |
| Timothy J Scannell | Direktor | 20. Mai 2026 A | 33.024 | 0 | 0 | $0 |
| Michael R Minogue | Direktor | 20. Mai 2026 A | 2.438 | 1 | 0 | $499.847 |
| Shacey Petrovic | Direktor | 28. Februar 2024 M | 2.567 | 0 | 0 | $0 |
| Corinne H Nevinny | Direktor | 23. Mai 2023 A | 6.010 | 0 | 0 | $0 |
| David A Lemoine | Direktor | 11. November 2021 M | 10.756 | 0 | 0 | $0 |
| John A. Fallon | Direktor | 21. Mai 2021 M | 14.498 | 0 | 0 | $0 |
| MULLEN JAMES C | Direktor | 16. Mai 2018 A | 7.783 | 0 | 0 | $0 |
| Joseph S Zakrzewski | Direktor | 17. Mai 2017 A | 30.558 | 0 | 0 | $0 |
| Regina O Sommer | Direktor | 17. Mai 2017 A | 23.039 | 0 | 0 | $0 |
| Steven Sobieski | Direktor | 13. Mai 2015 A | 16.039 | 0 | 0 | $0 |
| Charles T Liamos | Direktor | 1. April 2015 M | 87.575 | 0 | 0 | $0 |
| Mark W Lortz | Direktor | 3. Juni 2013 A | 4.000 | 0 | 0 | $0 |
| Ross A Jaffe MD | Direktor | 22. Februar 2012 S | 55.461 | 0 | 0 | $0 |
| Gary Eichhorn | Direktor | 20. April 2009 M | 70.749 | 0 | 0 | $0 |
| De Bord Alison Peyromaure | Direktor | 8. Mai 2008 A | 1.192.453 | 0 | 0 | $0 |
| ORBIMED ADVISORS LLC | Direktor | 18. Mai 2007 C | 1.568.841 | 0 | 0 | $0 |
| Jonathan Silverstein | Direktor | 15. Mai 2007 C | 1.568.841 | 0 | 0 | $0 |
| PRISM VENTURE PARTNERS III LP | 10%-Eigentümer | 5. Februar 2008 J | 0 | 0 | 0 | $0 |
| PRISM VENTURE PARTNERS III A LP | 10%-Eigentümer | 18. Mai 2007 C | 18.324 | 0 | 0 | $0 |
| Sally Crawford | · | 4. Juni 2021 S | 20.306 | 0 | 0 | $0 |
| Gordon E Nye | · | 18. Mai 2007 C | 627.537 | 0 | 0 | $0 |
| Prism Investment Partners III LP | · | 18. Mai 2007 C | 627.537 | 0 | 0 | $0 |
| Prism Venture Partners III LLC | · | 18. Mai 2007 C | 627.537 | 0 | 0 | $0 |
| William M Seifert | · | 18. Mai 2007 C | 627.537 | 0 | 0 | $0 |
| John L Brooks | · | 18. Mai 2007 C | 627.537 | 0 | 0 | $0 |
| PEQUOT CAPITAL MANAGEMENT INC | · | 18. Mai 2007 C | 2.134.289 | 0 | 0 | $0 |
| Samuel D Colella | · | 14. Mai 2007 C | 89.372 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 81 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| MEDI · Harbor ETF Trust | 2,10% | 5.226 NS | 31. Juli 2026 | N-PORT |
| RSPH · Invesco Exchange-Traded Fund Trust | 1,57% | 104.420 SH | 2. Oktober 2026 | Täglich |
| IHI · iShares Trust | 1,40% | 331.132 SH | 11. September 2026 | Täglich |
| RPG · Invesco Exchange-Traded Fund Trust | 0,54% | 79.722 SH | 2. Oktober 2026 | Täglich |
| QQQJ · Invesco Exchange-Traded Fund Trust … | 0,45% | 40.975 SH | 2. Oktober 2026 | Täglich |
| PALC · Pacer Funds Trust | 0,45% | 5.703 NS | 31. Juli 2026 | N-PORT |
| ISCG · iShares Trust | 0,31% | 22.170 SH | 11. September 2026 | Täglich |
| VBK · VANGUARD INDEX FUNDS | 0,29% | 917.724 SH | 19. August 2026 | Täglich |
| VFQY · VANGUARD WELLINGTON FUND | 0,28% | 8.788 SH | 19. August 2026 | Täglich |
| IWP · iShares Trust | 0,27% | 389.544 SH | 11. September 2026 | Täglich |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,25% | 30.632 NS | 31. Juli 2026 | N-PORT |
| RSP · Invesco Exchange-Traded Fund Trust | 0,19% | 1.415.137 SH | 2. Oktober 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,17% | 32.909 NS | 31. Juli 2026 | N-PORT |
| VHT · VANGUARD WORLD FUND | 0,16% | 208.067 SH | 19. August 2026 | Täglich |
| IYH · iShares Trust | 0,15% | 40.413 SH | 11. September 2026 | Täglich |
| JQUA · J.P. Morgan Exchange-Traded Fund Tr… | 0,14% | 67.413 NS | 31. Juli 2026 | N-PORT |
| CURE · Direxion Shares ETF Trust | 0,13% | 1.363 NS | 31. Juli 2026 | N-PORT |
| VB · VANGUARD INDEX FUNDS | 0,13% | 1.588.917 SH | 19. August 2026 | Täglich |
| SMMD · iShares Trust | 0,13% | 36.947 SH | 11. September 2026 | Täglich |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,12% | 24.602 SH | 2. Oktober 2026 | Täglich |
| IXJ · iShares Trust | 0,12% | 36.601 SH | 11. September 2026 | Täglich |
| RECS · Columbia ETF Trust I | 0,10% | 35.821 NS | 31. Juli 2026 | N-PORT |
| ESML · iShares Trust | 0,10% | 19.841 SH | 11. September 2026 | Täglich |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,09% | 5.613 SH | 2. Oktober 2026 | Täglich |
| WSML · iShares Trust | 0,08% | 4.139 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,08% | 70.592 NS | 31. Juli 2026 | N-PORT |
| IWR · iShares Trust | 0,07% | 284.401 SH | 11. September 2026 | Täglich |
| LRND · New York Life Investments ETF Trust | 0,06% | 1.564 NS | 31. Juli 2026 | N-PORT |
| CATH · Global X Funds | 0,05% | 4.302 NS | 31. Juli 2026 | N-PORT |
| XOEF · iShares Trust | 0,05% | 90 SH | 11. September 2026 | Täglich |
| DFSU · Dimensional ETF Trust | 0,04% | 5.400 NS | 31. Juli 2026 | N-PORT |
| CHRI · Global X Funds | 0,04% | 17 NS | 31. Juli 2026 | N-PORT |
| DXUV · Dimensional ETF Trust | 0,03% | 1.128 NS | 31. Juli 2026 | N-PORT |
| DFAC · Dimensional ETF Trust | 0,03% | 92.460 NS | 31. Juli 2026 | N-PORT |
| HAPI · Harbor ETF Trust | 0,03% | 896 NS | 31. Juli 2026 | N-PORT |
| EGLE · Global X Funds | 0,03% | 4 NS | 31. Juli 2026 | N-PORT |
| VOOG · VANGUARD ADMIRAL FUNDS | 0,03% | 51.531 SH | 19. August 2026 | Täglich |
| VONG · VANGUARD SCOTTSDALE FUNDS | 0,03% | 108.891 SH | 19. August 2026 | Täglich |
| GLBL · Pacer Funds Trust | 0,03% | 2 NS | 31. Juli 2026 | N-PORT |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,03% | 803 NS | 31. Juli 2026 | N-PORT |
| WRND · New York Life Investments ETF Trust | 0,03% | 18 NS | 31. Juli 2026 | N-PORT |
| IWF · iShares Trust | 0,03% | 259.928 SH | 11. September 2026 | Täglich |
| DSI · iShares Trust | 0,03% | 10.624 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,03% | 3.476 NS | 31. Juli 2026 | N-PORT |
| IVW · iShares Trust | 0,03% | 147.682 SH | 11. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,03% | 5.206 NS | 31. Juli 2026 | N-PORT |
| IUSG · iShares Trust | 0,03% | 61.820 SH | 11. September 2026 | Täglich |
| VOO · VANGUARD INDEX FUNDS | 0,02% | 1.797.121 SH | 19. August 2026 | Täglich |
| VONE · VANGUARD SCOTTSDALE FUNDS | 0,02% | 11.373 SH | 19. August 2026 | Täglich |
| ESGV · VANGUARD WORLD FUND | 0,02% | 15.641 SH | 19. August 2026 | Täglich |
| XYLD · Global X Funds | 0,02% | 3.708 NS | 31. Juli 2026 | N-PORT |
| XYLG · Global X Funds | 0,02% | 72 NS | 31. Juli 2026 | N-PORT |
| XCLR · Global X Funds | 0,02% | 4 NS | 31. Juli 2026 | N-PORT |
| PTLC · Pacer Funds Trust | 0,02% | 3.561 NS | 31. Juli 2026 | N-PORT |
| XRMI · Global X Funds | 0,02% | 53 NS | 31. Juli 2026 | N-PORT |
| BKLC · BNY Mellon ETF Trust | 0,02% | 5.732 NS | 31. Juli 2026 | N-PORT |
| TOPC · iShares Trust | 0,02% | 42 SH | 11. September 2026 | Täglich |
| SPUU · Direxion Shares ETF Trust | 0,02% | 261 NS | 31. Juli 2026 | N-PORT |
| XVV · iShares Trust | 0,02% | 806 SH | 11. September 2026 | Täglich |
| QDPL · Pacer Funds Trust | 0,02% | 1.658 NS | 31. Juli 2026 | N-PORT |
| RWL · Invesco Exchange-Traded Fund Trust … | 0,01% | 11.031 SH | 2. Oktober 2026 | Täglich |
| OMFL · Invesco Exchange-Traded Self-Indexe… | 0,01% | 5.214 SH | 2. Oktober 2026 | Täglich |
| IVV · iShares Trust | 0,01% | 873.214 SH | 11. September 2026 | Täglich |
| HCMT · Direxion Shares ETF Trust | 0,01% | 480 NS | 31. Juli 2026 | N-PORT |
| PBP · Invesco Exchange-Traded Fund Trust | 0,01% | 408 SH | 1. Oktober 2026 | Täglich |
| XTR · Global X Funds | 0,01% | 4 NS | 31. Juli 2026 | N-PORT |
| IYY · iShares Trust | 0,01% | 3.024 SH | 11. September 2026 | Täglich |
| IWB · iShares Trust | 0,01% | 48.747 SH | 11. September 2026 | Täglich |
| SPXL · Direxion Shares ETF Trust | 0,01% | 5.416 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,01% | 19.530 SH | 11. September 2026 | Täglich |
| ITOT · iShares Trust | 0,01% | 91.828 SH | 11. September 2026 | Täglich |
| PHDG · Invesco Actively Managed Exchange-T… | 0,01% | 53 SH | 1. Oktober 2026 | Täglich |
| QVML · Invesco Exchange-Traded Fund Trust … | 0,01% | 1.405 SH | 2. Oktober 2026 | Täglich |
| VTI · VANGUARD INDEX FUNDS | 0,01% | 2.199.830 SH | 19. August 2026 | Täglich |
| VT · VANGUARD INTERNATIONAL EQUITY INDEX… | 0,01% | 59.978 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,01% | 5.816 SH | 19. August 2026 | Täglich |
| VOXP · Advisors Series Trust | 0,01% | 3 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,01% | 10.297 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 2.582 NS | 31. Juli 2026 | N-PORT |
| DFUV · Dimensional ETF Trust | 0,00% | 23 NS | 31. Juli 2026 | N-PORT |
| ISCB · iShares Trust | · | 3.135 SH | 11. September 2026 | Täglich |
PODD Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 33 Analysten
KAUF
Median-Ziel
$167.50
+27,2%
9 27,3%
Starker Kauf
11 33,3%
Kauf
13 39,4%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
22 Analysten · 2026-09-27Mittelwert-Ziel $171.91 +30,5%
← Unter allen Zielen
Aktueller Preis $131.69
Tief$144.00
Mittelwert$171.91
Hoch$275.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| PODD | $20.01B | 81.7 | 30.7% | 9.1% | 16.6% | 71.6% |
| PEN | $12.20B | 68.8 | 17.5% | 12.7% | 13.1% | 67.1% |
| BAX | $13.05B | -10.2 | 5.7% | -8.5% | -14.6% | 30.0% |
| GMED | · | 22.3 | 16.7% | 18.3% | 12.1% | · |
| GKOS | $6.49B | -34.4 | 32.3% | -37.0% | -26.4% | 55.7% |
| TFX | · | -6.0 | 17.2% | -45.5% | -24.6% | 56.2% |
| ITGR | $2.69B | 27.1 | 8.0% | 5.5% | 6.0% | 27.0% |
| NVST | $3.56B | 77.5 | 8.3% | 1.7% | 1.5% | 54.7% |
| IRTC | $5.73B | -127.7 | 26.2% | -6.0% | -34.8% | 70.6% |
| ABT | $250.18B | 33.7 | 5.7% | 14.7% | 13.1% | · |
Neueste Nachrichten Aktuelle Schlagzeilen über dieses Unternehmen
Monday 6/8 Insider Buying Report: PODD, ADC
Nasdaq · 3 Monate, 3 Wochen vor
Sind Wall-Street-Analysten optimistisch für Insulet-Aktien?
Yahoo Finance · 4 Monate, 1 Woche vor
Warum Goldman Sachs das Kursziel für Insulet Corporation (PODD) trotz starker Q1-Ergebnisse senkte
Yahoo Finance · 4 Monate, 2 Wochen vor
BTIG hält Buy-Rating für Insulet (PODD)
Yahoo Finance · 5 Monate, 2 Wochen vor
Analysten sehen 75% Aufwärtspotenzial bei Insulet Corporation (PODD) trotz schwacher Aktienkursentwicklung
Yahoo Finance · 5 Monate, 3 Wochen vor
Unterperformt die Insulet-Aktie den Dow?
Yahoo Finance · 6 Monate, 1 Woche vor
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026